Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureNiall J. Dempster, Frederik Steensgaard Gade, Charlotte Daly, Richard Mbasu, Jiawen Dong, Elena Gangitano, Bruno Sgromo, Richard S. Gillies, Sarah White, Michelle Haylock, Ferenc E. Mózes, Kieran Smith, Helena Thomaides-Brears, Jeremy F. Cobbold, Ramneek Gupta, Garry D. Tan, Jeremy W. Tomlinson
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
2025
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
10.1016/s0140-6736(25)00355-1 · 2025
Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review
10.7570/jomes23052 · 2023
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
10.1097/hep.0000000000000004 · 2023
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
10.1016/s2468-1253(22)00165-0 · 2022
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
10.1016/s2468-1253(22)00317-x · 2023
Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management
10.1210/endrev/bnz009 · 2020
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
10.1002/hep.27368 · 2015
Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1053/j.gastro.2019.12.054 · 2020
An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease
10.1016/j.jhep.2023.01.024 · 2023
Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity
10.1016/j.bbadis.2013.05.029 · 2014
Androgens and the regulation of adiposity and body fat distribution in humans
10.1002/j.2040-4603.2018.tb00043.x · 2018
5α-reductase type 2 regulates glucocorticoid action and metabolic phenotype in human hepatocytes
10.1210/en.2015-1149 · 2015
Hepatic sexual dimorphism - implications for non-alcoholic fatty liver disease
10.1038/s41574-021-00538-6 · 2021
Association of Bariatric Surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis
10.1001/jama.2021.19569 · 2021
The change in the percent of android and gynoid fat mass correlated with increased testosterone after laparoscopic sleeve gastrectomy in Chinese obese men: a 6-month follow-up
10.1007/s11695-018-3116-0 · 2018
Five-year changes in body composition in type 2 diabetes mellitus patients with a BMI <32.5 kg/m
10.1007/s11695-021-05430-w · 2021
EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
10.1016/j.jhep.2024.04.031 · 2024
Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomy
10.1097/hc9.0000000000000444 · 2024
Role of ghrelin isoforms in the mitigation of hepatic inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress after bariatric surgery in rats
10.1038/s41366-019-0420-2 · 2020
Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD
10.1016/j.metabol.2023.155663 · 2023
Comparison of hormonal response to a mixed-meal challenge in hypoglycemia after sleeve gastrectomy vs gastric bypass
10.1210/clinem/dgac455 · 2022
Plasma concentration of gastrointestinal hormones and subjective appetite ratings after diet or bariatric surgery: 1-year results from the DISGAP study
10.1038/s41366-024-01658-5 · 2025
Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial
10.1016/s0140-6736(23)00634-7 · 2023
Role of estrogens in the regulation of liver lipid metabolism
10.1007/978-3-319-70178-3_12 · 2017
Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps
10.1002/hep.30626 · 2019
AlphaPept: a modern and open framework for MS-based proteomics
10.1038/s41467-024-46485-4 · 2024
DEqMS: a method for accurate variance estimation in differential protein expression analysis
10.1074/mcp.tir119.001646 · 2020
limma powers differential expression analyses for RNA-sequencing and microarray studies
10.1093/nar/gkv007 · 2015
Noise-augmented directional clustering of genetic association data identifies distinct mechanisms underlying obesity
10.1371/journal.pgen.1009975 · 2022
Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients
10.1016/j.jhep.2013.09.012 · 2014
The importance of endogenously secreted GLP-1 and GIP for postprandial glucose tolerance and β-cell function after roux-en-Y gastric bypass and sleeve gastrectomy surgery
10.2337/db22-0568 · 2023
Proteomic changes upon treatment with semaglutide in individuals with obesity
10.1038/s41591-024-03355-2 · 2025
Integrated proteomic and metabolomic profiling identifies distinct molecular signatures and metabolic pathways associated with obesity and potential targets for anti-obesity therapies
2025
Multi-omics profiling reveals altered mitochondrial metabolism in adipose tissue from patients with metabolic dysfunction-associated steatohepatitis
10.1016/j.ebiom.2024.105532 · 2025
Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity
10.1038/nature09968 · 2011
Proteome and phosphoproteome characterization of liver in the postprandial state from diet-induced obese and lean mice
10.1016/j.jprot.2020.104072 · 2021
Regional differences in subcutaneous adipose tissue gene expression
10.1038/oby.2012.117 · 2012
Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL magnetic resonance imaging randomized controlled trial
10.1161/circulationaha.117.030501 · 2018
Distinct abdominal and gluteal adipose tissue transcriptome signatures are altered by exercise training in African women with obesity
10.1038/s41598-020-66868-z · 2020
Sex differences in prevalence and prognosis of steatotic liver disease phenotypes: biological sex matters
10.1016/j.jhep.2023.08.013 · doi-reference
Obesity surgery makes patients healthier and more functional: real world results from the United Kingdom National Bariatric Surgery Registry
10.1016/j.soard.2018.02.012 · doi-reference
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management
10.1016/j.jhep.2014.11.034 · doi-reference
Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial
10.1016/s2213-8587(24)00396-6 · doi-reference
Roux-en-Y gastric bypass, adjustable gastric banding, or sleeve gastrectomy for severe obesity (By-Band-Sleeve): a multicentre, open label, three-group, randomised controlled trial
10.1016/s2213-8587(25)00025-7 · doi-reference
The natural metabolite 4-cresol improves glucose homeostasis and enhances β-cell function
10.1016/j.celrep.2020.01.066 · doi-reference
Effects of uremic toxin p-cresol on proliferation, apoptosis, differentiation, and glucose uptake in 3T3-L1 cells
10.1111/aor.12252 · doi-reference
Hepatic triglyceride content is intricately associated with numerous metabolites and biochemical pathways
10.1111/liv.15575 · doi-reference
The metabolomic profile associated with clustering of cardiovascular risk factors-a multi-sample evaluation
10.1371/journal.pone.0274701 · doi-reference
Metabolomic architecture of obesity implicates metabolonic lactone sulfate in cardiometabolic disease
10.1016/j.molmet.2021.101342 · doi-reference
Longitudinal analyses of the steroid metabolome in obese PCOS girls with weight loss
10.1530/ec-17-0051 · doi-reference
AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome
10.1210/jc.2017-00947 · doi-reference
Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process
10.1016/s0140-6736(26)00717-8 · doi-reference
Reduced glucocorticoid production rate, decreased 5alpha-reductase activity, and adipose tissue insulin sensitization after weight loss
10.2337/db08-0094 · doi-reference
Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT)
10.1210/jc.2014-4120 · doi-reference
Metabolomics-guided insights on bariatric surgery versus behavioral interventions for weight loss
10.1002/oby.21686 · doi-reference
Dynamics of the human bile acid metabolome during weight loss
10.1038/s41598-024-75831-1 · doi-reference
Metabolomic alterations in patients with obesity and the impact of metabolic bariatric surgery: insights for future research
10.3390/metabo15070434 · doi-reference
Effect of bariatric surgery on non-alcoholic fatty liver disease: an exploratory metabolomics and validation study
10.1007/s11695-025-08031-z · doi-reference
Multi-omics analysis of bariatric surgery’s impact on type 2 diabetes and prediabetes
10.1038/s41598-025-14577-w · doi-reference
Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis
10.1016/j.molmet.2018.10.007 · doi-reference
Adipose tissue depot-specific intracellular and extracellular cues contributing to insulin resistance in obese individuals
10.1096/fj.201902703r · doi-reference
Lumican modulates adipocyte function in obesity-associated type 2 diabetes
10.1080/21623945.2022.2154112 · doi-reference
2D-DIGE to identify proteins associated with gestational diabetes in omental adipose tissue
10.1530/joe-13-0010 · doi-reference
Lumican, a small leucine-rich proteoglycan
10.1002/iub.131 · doi-reference
Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease
10.1038/s41588-023-01497-6 · doi-reference
ADH1B, the adipocyte-enriched alcohol dehydrogenase, plays an essential, cell-autonomous role in human adipogenesis
10.1073/pnas.2319301121 · doi-reference
Epigenetic regulation of diabetogenic adipose morphology
10.1016/j.molmet.2019.04.009 · doi-reference
A comparison between the abdominal and femoral adipose tissue proteome of overweight and obese women
10.1038/s41598-019-40992-x · doi-reference
Further evidence supporting a potential role for ADH1B in obesity
10.1038/s41598-020-80563-z · doi-reference
Transcriptomic identification of ADH1B as a novel candidate gene for obesity and insulin resistance in human adipose tissue in Mexican Americans from the Veterans Administration Genetic Epidemiology Study (VAGES)
10.1371/journal.pone.0119941 · doi-reference